344 related articles for article (PubMed ID: 26739825)
21. Pathologic alterations of the outer retina in streptozotocin-induced diabetes.
Énzsöly A; Szabó A; Kántor O; Dávid C; Szalay P; Szabó K; Szél Á; Németh J; Lukáts Á
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3686-99. PubMed ID: 24845643
[TBL] [Abstract][Full Text] [Related]
22. PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy.
D'Amico AG; Maugeri G; Musumeci G; Reglodi D; D'Agata V
J Mol Neurosci; 2021 Aug; 71(8):1525-1535. PubMed ID: 33403597
[TBL] [Abstract][Full Text] [Related]
23. Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress.
Fabian E; Reglodi D; Mester L; Szabo A; Szabadfi K; Tamas A; Toth G; Kovacs K
J Mol Neurosci; 2012 Nov; 48(3):493-500. PubMed ID: 22644900
[TBL] [Abstract][Full Text] [Related]
24. PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype.
Wada Y; Nakamachi T; Endo K; Seki T; Ohtaki H; Tsuchikawa D; Hori M; Tsuchida M; Yoshikawa A; Matkovits A; Kagami N; Imai N; Fujisaka S; Usui I; Tobe K; Koide R; Takahashi H; Shioda S
J Mol Neurosci; 2013 Oct; 51(2):493-502. PubMed ID: 23720065
[TBL] [Abstract][Full Text] [Related]
25. Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells.
Mester L; Kovacs K; Racz B; Solti I; Atlasz T; Szabadfi K; Tamas A; Reglodi D
J Mol Neurosci; 2011 Jan; 43(1):35-43. PubMed ID: 20645022
[TBL] [Abstract][Full Text] [Related]
26. VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.
Amato R; Biagioni M; Cammalleri M; Dal Monte M; Casini G
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3066-76. PubMed ID: 27286364
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration.
Szabadfi K; Danyadi B; Kiss P; Tamas A; Fabian E; Gabriel R; Reglodi D
J Mol Neurosci; 2012 Nov; 48(3):501-7. PubMed ID: 22544514
[TBL] [Abstract][Full Text] [Related]
28. VIP, PACAP-38, BDNF and ADNP in NMDA-induced excitotoxicity in the rat retina.
Teuchner B; Dimmer A; Humpel C; Amberger A; Fischer-Colbrie R; Nemeth J; Waschek JA; Kieselbach G; Kralinger M; Schmid E; Bechrakis N; Troger J
Acta Ophthalmol; 2011 Nov; 89(7):670-5. PubMed ID: 20064115
[TBL] [Abstract][Full Text] [Related]
29. PACAP and VIP Inhibit HIF-1α-Mediated VEGF Expression in a Model of Diabetic Macular Edema.
Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
J Cell Physiol; 2017 May; 232(5):1209-1215. PubMed ID: 27661459
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
Zhang Y; Zhang J; Wang Q; Lei X; Chu Q; Xu GT; Ye W
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):278-85. PubMed ID: 20688733
[TBL] [Abstract][Full Text] [Related]
31. Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina.
Babai N; Atlasz T; Tamás A; Reglodi D; Tóth G; Kiss P; Gábriel R
Ann N Y Acad Sci; 2006 Jul; 1070():149-55. PubMed ID: 16888157
[TBL] [Abstract][Full Text] [Related]
32. Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents.
Werling D; Banks WA; Salameh TS; Kvarik T; Kovacs LA; Vaczy A; Szabo E; Mayer F; Varga R; Tamas A; Toth G; Biro Z; Atlasz T; Reglodi D
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335564
[TBL] [Abstract][Full Text] [Related]
33. Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice.
Yang XF; Huang YX; Lan M; Zhang TR; Zhou J
Chin Med J (Engl); 2018 Jan; 131(1):75-81. PubMed ID: 29271384
[TBL] [Abstract][Full Text] [Related]
34. PACAP improves functional outcome in excitotoxic retinal lesion: an electroretinographic study.
Varga B; Szabadfi K; Kiss P; Fabian E; Tamas A; Griecs M; Gabriel R; Reglodi D; Kemeny-Beke A; Pamer Z; Biro Z; Tosaki A; Atlasz T; Juhasz B
J Mol Neurosci; 2011 Jan; 43(1):44-50. PubMed ID: 20567936
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of semaphorin 4A expression in human retinal pigment epithelial cells by PACAP released from cocultured neural cells.
Ko JA; Hirata J; Yamane K; Sonoda KH; Kiuchi Y
Cell Biochem Funct; 2015 Jan; 33(1):29-36. PubMed ID: 25515530
[TBL] [Abstract][Full Text] [Related]
36. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.
Szabadfi K; Atlasz T; Kiss P; Danyadi B; Tamas A; Helyes Z; Hashimoto H; Shintani N; Baba A; Toth G; Gabriel R; Reglodi D
Neurotox Res; 2012 Jan; 21(1):41-8. PubMed ID: 21717232
[TBL] [Abstract][Full Text] [Related]
37. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Nilsson SF; De Neef P; Robberecht P; Christophe J
Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effect of PACAP against kainic acid-induced neurotoxicity in rat retina.
Seki T; Nakatani M; Taki C; Shinohara Y; Ozawa M; Nishimura S; Ito H; Shioda S
Ann N Y Acad Sci; 2006 Jul; 1070():531-4. PubMed ID: 16888220
[TBL] [Abstract][Full Text] [Related]
39. Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.
Babai N; Atlasz T; Tamás A; Reglödi D; Tóth G; Kiss P; Gábriel R
Neurotox Res; 2005 Nov; 8(3-4):227-33. PubMed ID: 16371317
[TBL] [Abstract][Full Text] [Related]
40. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways.
Rácz B; Gallyas F; Kiss P; Tóth G; Hegyi O; Gasz B; Borsiczky B; Ferencz A; Roth E; Tamás A; Lengvári I; Lubics A; Reglodi D
Regul Pept; 2006 Nov; 137(1-2):20-6. PubMed ID: 16945433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
